Pfizer Inc. DL-Notes 2018(18/28)

BID
-
ASK
-
0 Nom.0 Nom.
07/27, 22:00:04 PM

SPREAD (ACT/ REL)- / -
CHANGE COMPARED WITH PREVIOUS DAY (PRICE)0.06%
TODAY'S HIGH (PRICE)98.24
TODAY'S LOW (PRICE)98.17
Week 52 High (Price)99.96
Week 52 Low (Price)98.06

Yield Curves

Type of financial instrument

Corporate Bond

Sub-Type

Health Care

Yield

4.55

Yield spread Bundesanleihe

1.7698

Tradable for private investors

Minimum amount tradeable unit

2,000.00

Maturity

15/09/2028

Interest Rate

3.60 %

Currency

US Dollar

Facts & figures

Price data


TRADE PLATFORM
LAST PRICE / YIELD	98.202 G / 4.55	0 Units
PRICE DETERMINATION TIME	07/27/2026 / 09:46:18 PM
DAILY VOLUME (NOMINAL)	0
YIELD SPREAD	1.7698
FIXINGPRICE	-
DAILY HIGH / LOW	98.24	98.17
PREV. DAY'S PRICE	98.14	(07/24)
CHANGE DAY BEFORE	+0.06	0.06 %
52 WEEK HIGH / LOW	99.962 (10/17)	98.058 (07/23)

More Price Information

Master Data


WKN	A195R8
ISIN	US717081EP40
SYMBOL	-
EXCHANGE SEGMENT	Freiverkehr
TYPE OF FINANCIAL INSTRUMENT	Corporate Bond
SUB-TYPE	Health Care
ISSUER	Pfizer Inc.
S&P RATING	Please log in to view this field
(TRADING) SEGMENT / TICKS	-/ -
TRADING HOURS	07:30:00 AM - 10:00:00 PM
INTEREST RATE	3.60 %
INTEREST RUN FROM	07/09/2018
NEXT INTEREST PAYMENT	15/09/2026
UNIT INTEREST FROM NOMINAL AMMOUNT	1.34 %


TRADING CURRENCY / NOTATION	US Dollar/ Percent
NOMINAL CURRENCY	US Dollar
SETTLEMENT CURRENCY	Euro
QUOTATION	Continuous trading
ISSUING VOLUME	1.00 Bil.
MINIMUM AMOUNT TRADEABLE UNIT	2,000.00
SMALLEST TRADEABLE UNIT	1,000.00
MATURITY	15/09/2028
MARKET MAKER	-
STEP UP/ DOWN WHEN RATING CHANGES	No
STEP UP FIXED AT ISSUE	No
STEP DOWN FIXED AT ISSUE	No
BOND CALLABLE BY THE ISSUER	Yes
BOND IS SUBORDINATED	No

Description

Local currency bond: USD. Make Whole Call Option. Callable bond.

Tradability Information

Please log in to see the tradability information for this stock.

Not registered yet? Create your free account here.

Company profile

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.